1. Home
  2. Live Updates
  3. Orphan drug designation

Live Breaking News & Updates on Orphan drug designation

Stay informed with the latest breaking news from Orphan drug designation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Orphan drug designation and stay connected to the pulse of your community

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

CBL-514 is the first product to treat cellulite at the raised areas. Currently, there is no effective and safe cellulite treatment on the market. The global...

United-states , Taiwan , American , Fibrosclerotic-panniculopathy , Bax-bcl , American-society-of-plastic-surgeons , Hexsel-cellulite-severity-scale , Local-fat-reduction , Fast-track-designation , Orphan-drug-designation , Track-designation , Significant-reductions

Circio : Annual Report 2023 Report - MarketScreener

Annual Report 2023




25 April 2024








Annual Report...

Norway , Stockholm , Sweden , Washington , United-states , China , Brussels , Bruxelles-capitale , Belgium , Georgetown-university , District-of-columbia , Kansas

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints | Taiwan News

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.

United-states , Taiwan , American , Bax-bcl , Fibrosclerotic-panniculopathy , American-society-of-plastic-surgeons , Hexsel-cellulite-severity-scale , Local-fat-reduction , Fast-track-designation , Orphan-drug-designation , Track-designation , Significant-reductions

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.

United-states , Thailand , Taiwan , American , Bax-bcl , Fibrosclerotic-panniculopathy , American-society-of-plastic-surgeons , Hexsel-cellulite-severity-scale , Local-fat-reduction , Fast-track-designation , Orphan-drug-designation , Caliway-biopharmaceuticals

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

CBL-514 is the first product to treat cellulite at the raised areas.Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.CBL-0201EFP...

United-states , Taiwan , American , Fibrosclerotic-panniculopathy , Bax-bcl , American-society-of-plastic-surgeons , Cellulite-treatment-met-all-primary , Hexsel-cellulite-severity-scale , Local-fat-reduction , Fast-track-designation , Orphan-drug-designation , Track-designation

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Washington , United-states , Puerto-rico , Australia , Canada , North-carolina , Canadian , Albertd-friesen , Venture-exchange , Regulation-services-provider , Marley-drug-inc

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Australia , Liechtenstein , Germany , Melbourne , Victoria , Norway , Iceland , New-zealand , Switzerland , Eric-dube , Thomas-hutter , Emmanuelle-lecomte-brisset

Edgewise Receives European Medicines Agency Orphan Drug Designations for Sevasemten for the Treatment of Becker and Duchenne Muscular Dystrophies

BOULDER - Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that the European Medicines Agency has granted Orphan Drug Designations for sevasemten...

United-states , Maureen-franco , Michael-carruthers , Kevin-koch , Edgewise-therapeutics-inc , European-union , Nasdaq , European-medicines-agency , Drug-administration , Medicines-agency , Orphan-drug-designations , Receiving-orphan-drug

Capricor Therapeutics (CAPR) Announces Positive Type-B Meeting with FDA for CAP-1002

Capricor Therapeutics (CAPR) Announces Positive Type-B Meeting with FDA for CAP-1002
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , Los-angeles , Linda-marb , Drug-administration , Ns-pharma-inc , Capricor-therapeutics , Typeb-chemistry , Biologics-license-application , Non-clinical-comparability , Nippon-shinyaku

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan , United-states , San-diego , California , Linda-marb , Los-angeles , Dennis-riedl , Drug-administration , Twitter , Ns-pharma-inc , Instagram , Nasdaq